The systemic administration of CD24-Fc, is sufficient to suppress autoimmune responses in the heart, but appropriate timing of administration is critical in order to avoid suppression of the vaccine therapy effect as noted in this mouse neuroblastoma tumor model. Here, CD24 is linked to neuroblastoma.